Vycor Medical Inc
VYCO· OTC
Filed Aug 11, 2017 · 10-Q · 42 days after period end · 0001493152-17-008929
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $307.68K | $379.41K | $286.02K | $298.54K |
| Net Income | -$360.72K | -$305.36K | -$420.27K | -$1.28M |
| EPS Diluted | -$0.02 | -$0.03 | -$0.04 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 11, 2017 · 42 d after period end